CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $351 | +20.6% | 12,876 | -1.7% | 0.02% | +36.4% |
| Q2 2023 | $291 | -24.6% | 13,099 | -26.6% | 0.01% | -31.2% |
| Q1 2023 | $386 | +6.0% | 17,842 | -0.3% | 0.02% | 0.0% |
| Q4 2022 | $364 | -99.9% | 17,904 | -17.2% | 0.02% | -27.3% |
| Q3 2022 | $555,000 | -14.5% | 21,636 | -20.8% | 0.02% | +15.8% |
| Q2 2022 | $649,000 | +5.7% | 27,304 | +0.2% | 0.02% | +35.7% |
| Q1 2022 | $614,000 | -0.8% | 27,256 | -12.9% | 0.01% | +7.7% |
| Q4 2021 | $619,000 | +1.0% | 31,287 | +0.5% | 0.01% | -7.1% |
| Q3 2021 | $613,000 | -14.1% | 31,137 | -4.1% | 0.01% | 0.0% |
| Q2 2021 | $714,000 | +23.1% | 32,477 | +33.3% | 0.01% | +16.7% |
| Q1 2021 | $580,000 | -9.5% | 24,371 | -0.6% | 0.01% | -7.7% |
| Q4 2020 | $641,000 | +50.1% | 24,511 | 0.0% | 0.01% | +30.0% |
| Q3 2020 | $427,000 | +3.6% | 24,511 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $412,000 | – | 24,511 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |